Showing results (21-30 of 56) with videos related to
Sort By:
Pageof 6
The New England Journal of Medicine|November 13, 2020
Polypill with or without Aspirin in Persons without Cardiovascular DiseaseSalim Yusuf, Philip Joseph, Antonio Dans, et al.Diabetes, Obesity & Metabolism|January 5, 2022
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trialPeter J Raubenheimer, William C Cushman, Alvaro Avezum, et al.Journal of the American College of Cardiology|January 19, 2019
Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG StudyAndre Lamy, John Eikelboom, Tej Sheth, et al.Neurology|March 1, 2019
Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 studyJackie Bosch, Martin O'Donnell, Balakumar Swaminathan, et al.Lancet (London, England)|August 30, 2011
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological surveySalim Yusuf, Shofiqul Islam, Clara K Chow, et al.The Canadian Journal of Cardiology|October 12, 2015
Assessment of Dietary Sodium and Potassium in Canadians Using 24-Hour Urinary CollectionAndrew Mente, Gilles Dagenais, Andreas Wielgosz, et al.The Canadian Journal of Cardiology|December 6, 2014
Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery position statement on revascularization--multivessel coronary artery diseaseKoon K Teo, Eric Cohen, Christopher Buller, et al.Annals of Neurology|November 28, 2014
Early cerebral small vessel disease and brain volume, cognition, and gaitEric E Smith, Martin O'Donnell, Gilles Dagenais, et al.Journal of Hypertension|February 27, 2014
Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countriesAndrew Mente, Martin J O'Donnell, Gilles Dagenais, et al.The Lancet. Public Health|December 19, 2017
Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study dataMarjan W Attaei, Rasha Khatib, Martin McKee, et al.Pageof 6